Advertisement
Two experimental vaccines might help protect human fetuses against the Zika virus

New Vaccines Show Promise in Protecting Fetus From Zika

0
Experimental study shows the vaccines protected unborn baby mice from the virus
Abuse of prescription opioids is second only to marijuana abuse as the most common illegal drug problem in the United States

Opioids Second Only to Marijuana in Illicit Drug Abuse Rates

0
SAMHSA report identifies states with highest rates of abuse
For patients with grass pollen-induced allergic rhinitis

Booster Allergen Immunotx Cuts Symptoms in Allergic Rhinitis

0
Ultra-short-course booster AIT prevents symptom recurrence in grass pollen-induced allergic rhinitis
For older patients receiving prednisolone

Alendronate Cuts Hip Fx Risk in Seniors Taking Prednisolone

0
No association for alendronate treatment with risk of mild upper GI symptoms, peptic ulcers
Parents of children at increased genetic risk for type 1 diabetes and with positive islet autoantibody testing have increased anxiety

Increased Parental Anxiety With Increased Diabetes Risk

0
Anxiety up for parents of children at increased genetic risk with positive islet autoantibody testing
About one-third of patients with inactive intestinal Behçet's disease have small intestinal bacterial overgrowth

More Than 1 in 3 With Behçet’s Has Bacterial Overgrowth

0
Six of seven patients taking rifaximin reported improvement in symptoms after four weeks
Vitamin D supplementation seems not to prevent allergies in pregnant women

Review: Little Evidence on Vitamin D-Allergy Association

0
Appears to be no decrease in risk of allergic disease for pregnant and breastfeeding women, infants
For patients with major depressive disorder

Addition of Aripiprazole Ups Major Depressive Disorder Remission

0
Small increased likelihood of remission at 12 weeks in patients with major depressive disorder
Medicaid enrollees are largely satisfied with their health care

Medicaid Enrollees Are Satisfied With Their Health Care

0
Enrollees rate their overall health care at 7.9, on average, on a scale of 1 to 10
The safety and efficacy of rivaroxaban treatment for nonvalvular atrial fibrillation in patients with active cancer is similar to the general population

Rivaroxaban OK for Stroke Prevention in Cancer Patients

0
Safety, efficacy in cancer patients similar to the general population